What is Niagen and Its Effects on the Body
Niagen is nicotinamide riboside (NR), a form of vitamin B3 that serves as a precursor to NAD+ (nicotinamide adenine dinucleotide), a critical coenzyme involved in cellular energy metabolism, DNA repair, and over 400 enzymatic reactions in the body. 1
Mechanism and Metabolic Effects
NR functions by converting to NAD+ in tissues, which is essential for:
- Energy metabolism: Converting nutrients into cellular energy
- DNA synthesis and repair: Supporting genetic material maintenance
- Cholesterol and fat metabolism: Participating in lipid synthesis pathways
- Antioxidant effects: Protecting against oxidative stress 1
However, recent metabolic studies reveal an unexpected pathway: most orally administered NR undergoes gut microbiota-mediated conversion to nicotinic acid (NA) rather than direct absorption, with subsequent NAD+ synthesis occurring via enterohepatic circulation 2. This means NR may work differently than originally theorized.
Clinical Effects in Humans
The evidence for clinical benefits is mixed and generally modest:
Demonstrated effects:
- NAD+ elevation: NR supplementation (100-1000 mg/day) dose-dependently increases whole blood NAD+ levels by 22-142% within 2 weeks, with effects sustained over 8 weeks 3
- Body composition: Minor increase in fat-free mass (1.34%) and sleeping metabolic rate 4
- Skeletal muscle metabolism: Increased acetylcarnitine concentrations, suggesting altered muscle energy metabolism 4
- Safety profile: Well-tolerated with no flushing (unlike nicotinic acid) and no significant adverse events at doses up to 1000 mg/day for 6-8 weeks 3, 5
Limited or absent effects:
- No significant improvements in insulin sensitivity, mitochondrial function, hepatic lipid accumulation, cardiac function, blood pressure, or inflammatory markers in most studies 4, 6
- Cognitive outcomes: A 2025 trial in long-COVID patients showed no significant between-group differences in cognition, fatigue, sleep, or mood versus placebo, despite 2.6-3.1 fold NAD+ increases 7
- Critical assessment: A 2023 comprehensive review concluded that "oral nicotinamide riboside supplementation has displayed few clinically relevant effects, and there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects" 6
Drug Interactions
The evidence regarding medication interactions with NR supplementation is notably limited. The 2021 guideline on drug-nutrient interactions acknowledges that "adverse effects of medications on nutrient status are generally not well studied" and that "causal and quantitative relationships between drugs and nutrients are exceptionally hard to elucidate" 8.
What We Know:
No documented interactions in clinical trials: Studies of NR supplementation up to 1000 mg/day for 8 weeks showed:
- No elevation of LDL cholesterol
- No dysregulation of 1-carbon metabolism
- No significant adverse events compared to placebo 3
Theoretical considerations based on niacin family:
- Unlike nicotinic acid (which causes flushing and can interact with antihypertensives), NR does not produce flushing even at 1000 mg/day 3
- The upper limit for nicotinamide is 900 mg/day for adults (12.5 mg/kg/day), with no flushing effects 1
- Nicotinic acid can cause hepatotoxicity at ~3g/day and has cardiovascular effects, but these are not documented with NR at studied doses 1
Clinical Caution:
Given the lack of specific interaction data, monitor patients taking NR who are on:
- Medications metabolized via pathways requiring NAD+ cofactors
- Drugs affecting mitochondrial function
- Medications with narrow therapeutic windows
The 2022 ESPEN guidelines note that current professional guidelines "often do not provide specific recommendations for monitoring or optimal methods for prophylactically managing or treating" drug-nutrient interactions 8.
Important Caveats
Recent mechanistic findings challenge earlier assumptions: The 2025 discovery that NR is primarily converted to nicotinic acid via gut microbiota rather than directly absorbed suggests that individual variations in gut microbiome composition may significantly affect NR efficacy 2.
Potential stress sensitivity: A 2025 study in aged mice found that while NR enhanced immune parameters, it also increased anxiety-like behaviors and stress sensitivity, suggesting "a dual role for NR in potentially enhancing immune function while exacerbating behavioral responses to stress" 9. This warrants consideration in patients with anxiety disorders or high stress levels.
Dropout rates: Clinical trials show concerning dropout rates (32-51% in some studies), potentially indicating tolerability issues not captured by formal adverse event reporting 7.